Ad
related to: livedeal stock price quote glp news headlinessuperstockscreener.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Another GLP-1 drug, Trulicity, which is also used to treat type 2 diabetes, was its third-best-selling drug, but saw its sales fall 31% to $1.25 billion as patients shifted to its newer GLP-1 ...
Given the popularity of GLP-1 drugs and the potential for an oral GLP-1 drug launch in 2026, Lilly remains very well positioned. As such, I think the stock still looks attractive at current levels.
Amgen's positive trial results update on its GLP-1 injectable for obesity, MariTide, sent its stock up more than 13% in trading Friday.CEO Bob Bradway shared a peek at phase II results of the ...
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here. Finance News & Latest Business Headlines - AOL.com
Novo Nordisk CEO Lars Jørgensen isn't too worried about the upcoming Medicare price negotiations over blockbuster GLP-1 drugs, even though the company still stands with the industry against the ...
The drugs, known as GLP-1s, have brought in $50 billion in revenue for Novo Nordisk year to date alone, but the high prices ($1,349 for Wegovy and $968 for Ozempic) have put them out of reach for ...
The stock was up more than 10% on the news Thursday morning. Mizuho's health sector expert Jared Holz said in a note Thursday that the beat on earnings should allay any fears of the pace of uptake ...
The good news for investors is that for 2025, overall guidance is looking strong. Lilly is projecting between $58 billion and $61 billion in sales, which is mostly higher than the $58.4 billion ...
Ad
related to: livedeal stock price quote glp news headlinessuperstockscreener.com has been visited by 10K+ users in the past month